...
首页> 外文期刊>Clinical drug investigation >A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis
【24h】

A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis

机译:依拉拉唑治疗反流性食管炎的随机,双盲,主动控制,多中心研究

获取原文
获取原文并翻译 | 示例
           

摘要

Proton pump inhibitors (PPIs) are the main drugs for the treatment of reflux esophagitis. Previous studies have indicated ilaprazole to be safer and more effective in treating duodenal ulcers as compared with omeprazole. Being a novel PPI, ilaprazole may be used in the treatment of reflux esophagitis. The purpose of this study was to evaluate the safety and efficacy of ilaprazole tablets in the treatment of reflux esophagitis.
机译:质子泵抑制剂(PPI)是治疗反流性食管炎的主要药物。先前的研究表明,与奥美拉唑相比,艾拉拉唑治疗十二指肠溃疡更安全,更有效。作为一种新型的PPI,艾拉拉唑可用于治疗反流性食管炎。这项研究的目的是评估艾拉拉唑片治疗反流性食管炎的安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号